CHICAGO EQUITY PARTNERS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$450,000
-26.4%
6,190
+5.6%
0.04%
+28.6%
Q4 2019$611,000
+11.7%
5,860
+6.6%
0.04%
+34.6%
Q3 2019$547,000
-48.6%
5,495
-41.1%
0.03%
-44.7%
Q2 2019$1,065,000
-70.4%
9,330
-67.4%
0.05%
-66.2%
Q1 2019$3,597,000
+3.4%
28,615
+11.6%
0.14%
-0.7%
Q4 2018$3,480,000
-47.2%
25,645
+6.8%
0.14%
-27.8%
Q3 2018$6,593,000
+91.7%
24,020
+44.7%
0.19%
+84.8%
Q2 2018$3,439,000
+35.1%
16,600
+7.7%
0.10%
+29.6%
Q1 2018$2,545,00015,4100.08%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders